Literature DB >> 26197891

Effects of miRNA-145 on airway smooth muscle cells function.

Yun Liu1, Xiuzhen Sun2, Yuanyuan Wu2, Ping Fang2, Hongyang Shi2, Jing Xu2, Manxiang Li2.   

Abstract

The pathological changes of airway smooth muscle (ASM) contribute to airway remodeling during asthma. Here, we investigated the effect of miR-145 on ASM function. We found that miR-145 was aberrantly more highly expressed in ASM cells exposed to cytokine stimulation that mimic the airway conditions of patients with asthma. Repression of miR-145 resulted in decreased ASM cell proliferation and migration in a dose-dependent manner and down-regulation of type I collagen and contractile protein MHC in ASM cells. qRT-PCR and Western blot analysis demonstrated that miR-145 negatively regulated the expression of downstream target Krüppel-like factor 4 (KLF4) protein, and overexpression of KLF4 attenuated the effects of miR-145 on ASM cells. Further studies showed that KLF4 significantly up-regulated the expression of p21 and down-regulated matrix metalloproteinase (MMP-2 and MMP-9). In conclusion, miR-145 overexpression in ASM cells significantly inhibited KLF4, and subsequently affected downstream p21, MMP-2, and MMP-9 expressions, eventually leading to enhanced proliferation and migration of ASM cells in vitro.

Entities:  

Keywords:  Airway remodeling; Airway smooth muscle cells; KLF4; MMP-2; miRNA-145; p21

Mesh:

Substances:

Year:  2015        PMID: 26197891     DOI: 10.1007/s11010-015-2519-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Airway structural alterations selectively associated with severe asthma.

Authors:  Laurent Benayoun; Anne Druilhe; Marie-Christine Dombret; Michel Aubier; Marina Pretolani
Journal:  Am J Respir Crit Care Med       Date:  2003-01-16       Impact factor: 21.405

2.  down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4.

Authors:  Brandi N Davis-Dusenbery; Mun Chun Chan; Kelsey E Reno; Alexandra S Weisman; Matthew D Layne; Giorgio Lagna; Akiko Hata
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

3.  Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment.

Authors:  Adam Collison; Joerg Mattes; Maximilian Plank; Paul S Foster
Journal:  J Allergy Clin Immunol       Date:  2011-05-14       Impact factor: 10.793

4.  Role of miR-145 in cardiac myofibroblast differentiation.

Authors:  Yao-Sheng Wang; Shu-Hong Li; Jian Guo; Anton Mihic; Jun Wu; Lu Sun; Kelly Davis; Richard D Weisel; Ren-Ke Li
Journal:  J Mol Cell Cardiol       Date:  2013-08-31       Impact factor: 5.000

5.  Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.

Authors:  Diana Dahan; Mari Ekman; Anna-Karin Larsson-Callerfelt; Karolina Turczyńska; Thomas Boettger; Thomas Braun; Karl Swärd; Sebastian Albinsson
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-01       Impact factor: 4.249

6.  Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta.

Authors:  Omar Tliba; Samira Tliba; Chien Da Huang; Rebecca K Hoffman; Peter DeLong; Reynold A Panettieri; Yassine Amrani
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

7.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

8.  Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma.

Authors:  H-U Simon; H Seelbach; R Ehmann; M Schmitz
Journal:  Allergy       Date:  2003-12       Impact factor: 13.146

Review 9.  Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function.

Authors:  Rachel L Clifford; Cherie A Singer; Alison E John
Journal:  Pulm Pharmacol Ther       Date:  2012-07-16       Impact factor: 3.410

10.  MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.

Authors:  W Tang; Y Zhu; J Gao; J Fu; C Liu; Y Liu; C Song; S Zhu; Y Leng; G Wang; W Chen; P Du; S Huang; X Zhou; J Kang; L Cui
Journal:  Br J Cancer       Date:  2013-11-26       Impact factor: 7.640

View more
  15 in total

Review 1.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

Review 2.  Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.

Authors:  Madhur D Shastri; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Malik Q Mahmood; Murtaza Tambuwala; Dinesh K Chellappan; Nicole G Hansbro; Shakti D Shukla; Philip M Hansbro
Journal:  Inflammopharmacology       Date:  2020-11-05       Impact factor: 4.473

3.  Glycoprotein non-metastaticmelanoma protein B promotes glioma motility and angiogenesis through the Wnt/β-catenin signaling pathway.

Authors:  Gang Bao; Ning Wang; Ruichun Li; Gaofeng Xu; Peijun Liu; Baixiang He
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-21

4.  Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.

Authors:  Donato Lacedonia; Grazia Pia Palladino; Maria Pia Foschino-Barbaro; Giulia Scioscia; Giovanna Elisiana Carpagnano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-06-23

5.  Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma.

Authors:  Julie Weidner; Linda Ekerljung; Carina Malmhäll; Nicolae Miron; Madeleine Rådinger
Journal:  Respir Res       Date:  2020-05-07

6.  MicroRNA-590-5p represses proliferation of human fetal airway smooth muscle cells by targeting signal transducer and activator of transcription 3.

Authors:  Shan Shi; Lianhua Jin; Sai Zhang; Haibo Li; Bo Zhang; Meihua Sun
Journal:  Arch Med Sci       Date:  2018-03-21       Impact factor: 3.318

7.  Transforming Growth Factor-β1 Selectively Recruits microRNAs to the RNA-Induced Silencing Complex and Degrades CFTR mRNA under Permissive Conditions in Human Bronchial Epithelial Cells.

Authors:  Nilay Mitash; Fangping Mu; Joshua E Donovan; Michael M Myerburg; Sarangarajan Ranganathan; Catherine M Greene; Agnieszka Swiatecka-Urban
Journal:  Int J Mol Sci       Date:  2019-10-05       Impact factor: 5.923

8.  COPD-associated miR-145-5p is downregulated in early-decline FEV1 trajectories in childhood asthma.

Authors:  Anshul Tiwari; Jiang Li; Alvin T Kho; Maoyun Sun; Quan Lu; Scott T Weiss; Kelan G Tantisira; Michael J McGeachie
Journal:  J Allergy Clin Immunol       Date:  2020-12-29       Impact factor: 10.793

9.  MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression.

Authors:  Zhe Cheng; Ling-Ling Dai; Xi Wang; Liu-Qun Jia; Xiao-Gang Jing; Peng-Fei Li; Meng Liu; Huan Wang; Lin An
Journal:  Oncotarget       Date:  2017-07-11

10.  Nanoparticle Delivery of Anti-inflammatory LNA Oligonucleotides Prevents Airway Inflammation in a HDM Model of Asthma.

Authors:  Sabrina C Ramelli; Brian S Comer; Jared M McLendon; Lydia L Sandy; Andrew P Ferretti; Robert Barrington; Jeff Sparks; Majed Matar; Jason Fewell; William T Gerthoffer
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-14       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.